Home > Publications database > Novel dietary herbal preparations with inhibitory activities against multiple SARS-CoV-2 targets: A multidisciplinary investigation into antiviral activities > print |
001 | 1043723 | ||
005 | 20250717202252.0 | ||
024 | 7 | _ | |a 10.1016/j.focha.2025.100969 |2 doi |
024 | 7 | _ | |a 10.34734/FZJ-2025-03009 |2 datacite_doi |
037 | _ | _ | |a FZJ-2025-03009 |
082 | _ | _ | |a 660 |
100 | 1 | _ | |a Olubiyi, Olujide Oludayo |0 P:(DE-Juel1)138971 |b 0 |e Corresponding author |
245 | _ | _ | |a Novel dietary herbal preparations with inhibitory activities against multiple SARS-CoV-2 targets: A multidisciplinary investigation into antiviral activities |
260 | _ | _ | |a [Amsterdam] |c 2025 |b Elsevier |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1752742609_3508 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a The outbreak of the COVID-19 pandemic has resulted in not <7.1million deaths globally as of December 2024. Many new variants of concern have continued to emerge since the initial outbreak of the original SARS-CoV-2 virus traceable to the Wuhan strain (Wuhan-Hu-1). In this work, the therapeutic potentials of four new polyherbal dietary preparations – VIVE (five plants), FORTE1(fortified VIVE), COMBI-5 (five spices) and MOK (Moringa seed) as well as four individual ethnomedicinal plants were investigated. Computational screening revealed chemical structures capable of establishing moderate to strong interaction with SARS-CoV-2′s main protease enzyme, while in vitro screening against the viral protease clearly established inhibitory potencies. The individual plant extracts making up VIVE and FORTE1 showed mild (494.9 ± 19.6 µg/ml) to moderate (21.5 ± 1.1 µg/ml) inhibitory activity against the viral enzyme in vitro; highest activity was obtained in the polyherbal VIVE preparation (17.3 ± 1.4 µg/ml). The MOK exerted total inhibition – 100 % (IC50 -3.6 ± 0.9) of the viral enzyme while COMBI-5 produced an inhibition of 95 %(IC50 - 0.9 ± 0.1). These results revealed the potential of specialized metabolites within these widely consumed dietary herbal products for the management of COVID-19 and related viral threats. |
536 | _ | _ | |a 5241 - Molecular Information Processing in Cellular Systems (POF4-524) |0 G:(DE-HGF)POF4-5241 |c POF4-524 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de |
700 | 1 | _ | |a Attah, Francis Alfred |0 0000-0003-0787-0204 |b 1 |
700 | 1 | _ | |a Strodel, Birgit |0 P:(DE-Juel1)132024 |b 2 |u fzj |
700 | 1 | _ | |a Eberle, Raphael Josef |0 P:(DE-Juel1)179561 |b 3 |
700 | 1 | _ | |a Coronado, Monika Aparecida |b 4 |
700 | 1 | _ | |a Akinseinde, Oluwadotun |0 P:(DE-HGF)0 |b 5 |
700 | 1 | _ | |a Onyeaghala, Augustine Anayochukwu |0 P:(DE-HGF)0 |b 6 |
700 | 1 | _ | |a Uzochukwu, Ikemefuna Chijioke |0 P:(DE-HGF)0 |b 7 |
700 | 1 | _ | |a Kotila, Olayinka Adejoke |0 P:(DE-HGF)0 |b 8 |
700 | 1 | _ | |a Dada-Adegbola, Hannah |0 P:(DE-HGF)0 |b 9 |
700 | 1 | _ | |a Adepiti, Awodayo Oluwatoyin |0 P:(DE-HGF)0 |b 10 |
700 | 1 | _ | |a Elujoba, Anthony Adebolu |0 P:(DE-HGF)0 |b 11 |
700 | 1 | _ | |a Babalola, Chinedum Peace |0 P:(DE-HGF)0 |b 12 |e Corresponding author |
773 | _ | _ | |a 10.1016/j.focha.2025.100969 |g Vol. 7, p. 100969 - |0 PERI:(DE-600)3116248-4 |p 100969 - |t Food chemistry advances |v 7 |y 2025 |x 2772-753X |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/1043723/files/1-s2.0-S2772753X25000851-main.pdf |y OpenAccess |
909 | C | O | |o oai:juser.fz-juelich.de:1043723 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 2 |6 P:(DE-Juel1)132024 |
913 | 1 | _ | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-524 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Molecular and Cellular Information Processing |9 G:(DE-HGF)POF4-5241 |x 0 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-05 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2022-04-11T11:05:44Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2022-04-11T11:05:44Z |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2022-04-11T11:05:44Z |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2024-12-05 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-05 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2024-12-05 |
920 | _ | _ | |l yes |
920 | 1 | _ | |0 I:(DE-Juel1)IBI-7-20200312 |k IBI-7 |l Strukturbiochemie |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-Juel1)IBI-7-20200312 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|